Pre-made Dulaglutide benchmark antibody (Peptide Protein fusion , anti-GLP1R therapeutic antibody, Anti-GLP-1/GLP-1-R/GLP-1R Antibody) for drug discovery and mechanism of action (MOA) research

Cat No.: GMP-Bios-INN-806

Pre-made Dulaglutide benchmark antibody (Peptide Protein fusion , anti-GLP1R therapeutic antibody, Anti-GLP-1/GLP-1-R/GLP-1R Antibody) is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for biological drug disovery items including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.



Order information


* GeneMedi provides NON-PROFIT PRICE to support Academic research. Please click inquiry for product quotation. → Inquiry

Catalog No. Package Price(In USD) Qty (Quantity) Sum(In USD)
GMP-Bios-INN-806-1mg 1mg 3090
GMP-Bios-INN-806-10mg 10mg Inquiry
GMP-Bios-INN-806-100mg 100mg Inquiry
GMP-Bios-INN-806-xmg ≥100mg Inquiry
Shipping Cost: 760.00
Total:

For more than 100mg, click here for inquiry. >>


Description

Products Name (INN Index) Pre-Made Dulaglutide Biosimilar, Peptide Protein Fusion targeting GLP1R: (Glp-12) Peptide-Human Igg4 Fc Fusion Protein targeting GLP-1/GLP-1-R/GLP-1R
INN Name Dulaglutide
TargetGLP1R
FormatPeptide Protein fusion
Derivationhuman
Species Reactivityhuman
CH1 IsotypeFusion - [GCG (glucagon) 98-127 (glucagon-like peptide 1, GLP1) 7- 36]2 - IGHG4 Fc (Fragment constant)
VD LCFusion - [GCG (glucagon) 98-127 (glucagon-like peptide 1, GLP1) 7- 36]2 - IGHG4 Fc (Fragment constant)
Highest_Clin_Trial (Jan '20)
Est. Status
100% SI Structure
99% SI Structure
95-98% SI Structure
Year Proposed
Year Recommended
CompaniesEli Lilly (Indianapolis IN USA)
Conditions Approved
Conditions Active
Conditions Discontinued
Development Tech0